For those unfamiliar, semaglutide is a drug originally developed for diabetes treatment that has shown extremely promising results against obesity, and prompted some interesting analysis in a...
For those unfamiliar, semaglutide is a drug originally developed for diabetes treatment that has shown extremely promising results against obesity, and prompted some interesting analysis in a wider public health context.
Retailers have not said how much the service will cost, but according to draft guidelines for the NHS, the list price for a month's supply of four pre-filled disposable injection pens is £73.25.
[...]
In trials, used alongside a healthy diet and exercise, semaglutide helped obese people lose a 10th of their body weight - about two stone (12.7kg) on average.
A spokesperson at Boots said: "It can be an effective medicine to achieve sustained weight loss when used alongside a reduced calorie diet, increased physical activity and healthy lifestyle choices. It will be available from Boots Online Doctor, with an anticipated launch of spring 2023.
"The Boots Online Doctor Weight Loss Treatment service is for customers who are worried that their weight is impacting their health. Customers will have access to treatment following their completion of an online consultation form, which will be assessed by a clinician.
Basically, it's been approved for private healthcare providers to distribute, and the major retail pharmacies can see the potential profit like this a mile off - seems like it'll pretty much be a brief questionnaire on the website that gets a cursory glance from someone licensed to sign off on it, ballpark £100/month cost, and that's that. Given the effectiveness, likely affordability, and the social stigma of obesity driving people to seek it out, this could be a game changer.
For those unfamiliar, semaglutide is a drug originally developed for diabetes treatment that has shown extremely promising results against obesity, and prompted some interesting analysis in a wider public health context.
[...]
Basically, it's been approved for private healthcare providers to distribute, and the major retail pharmacies can see the potential profit like this a mile off - seems like it'll pretty much be a brief questionnaire on the website that gets a cursory glance from someone licensed to sign off on it, ballpark £100/month cost, and that's that. Given the effectiveness, likely affordability, and the social stigma of obesity driving people to seek it out, this could be a game changer.